Popular Articles

Nile Therapeutics, Inc. Announces Dosing Of First Patient In Phase 2 Study Of CD-NP For The Treatment Of Acute Heart Failure
Nile Therapeutics, Inc. (Nasdaq: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced dosing of its first patient in a Phase 2 clinical study of its lead product, CD-NP, for the treatment of acute heart failure.
pharmacy online Dentisti fiume
Patients In St. Jude Medical Deep Brain Stimulation For Depression Pilot Study Demonstrate Sustained Improvement In Depression Symptoms
According to the latest data in a clinical study supported by St. Jude Medical, Inc. (NYSE:STJ), deep brain stimulation (DBS) therapy for depression may provide sustainable improvement in depression symptoms among patients with major depressive disorder. Study results will be presented at the American Psychiatric Association (APA) meeting in San Francisco.
News of the day
Large African American Study May Lead To Treatment And Prevention Of Hypertension
Researchers from the Coriell Institute for Medical Research and the National Human Genome Research Institute (NHGRI) have announced the discovery of five sites of variation in the genome that are associated with blood pressure in African Americans.
Diagnostics

Pioneering Research Into Healing Power Of Sugar

A pioneering University of Wolverhampton lecturer has won a ÷£25,000 grant to research the healing effect of sugar on cuts and wounds. Senior Lecturer Moses Murandu grew up in Zimbabwe and his father used granulated sugar to heal wounds and reduce pain when he was a child. But when he moved to the UK, he realised that sugar was not used for this purpose here. Moses, 43, carried out research into the effect of sugar on patients" wounds on the vascular ward at Selly Oak Hospital in Birmingham, funding the study himself for six months. He has now been awarded the prestigious Fondation Le Lous Scientific Research Innovation Award and ÷£25,000 to enable him to continue his innovative work. Sugar can be used on wounds such as bed sores, leg ulcers and even amputations. It works because bacteria needs water to grow, so applying sugar to a wound draws the water away and starves the bacteria of water. This prevents the bacteria from multiplying and they die. Moses found that a 25% sugar concentration ensures the microorganisms cannot survive. Mr Murandu, Senior Lecturer in Adult Nursing at the School of Health and Well Being, said: "Using granulated sugar in wounds has never been done in the UK before, although sugar paste has been used. When I was a child, my father used sugar or salt and I grew up without realising that something that works is not widely used. "While salt is painful, sugar is not and reduces the pain drastically. The patients we have tested it on in the pilot study have said that they never knew such a simple method could make such a difference to their quality of life. "I was happy for the patients who suffer from terrible and debilitating wounds with little hope of getting better, as this treatment can ease their pain." Jacqui Fletcher, Herve Le Lous Board Member, said: "Moses was awarded the prize not just because the quality of his proposal was excellent, but also because he challenged current thinking. In the UK we have a habit of saying "Ah yes we know in countries that can"t afford proper dressings they use other things, but when you are here you have the freedom and luxury of choosing a whole range of alternatives", but Moses didn"t think that way. He takes the view that he used sugar very effectively, therefore why wouldn"t it work equally well here? He should be commended for his tenacity in taking this project forward when many others would not even have started." Moses, from Edgbaston in Birmingham, was supported in his studies by Mr Malcolm Simms, consultant vascular surgeon at Selly Oak Hospital, who had worked in Uganda and witnessed the use of sugar there. Mr Murandu submitted an abstract to the Fondation Le Lous detailing his study and the benefits for patients. As well as ÷£25,000 over two years to further his research, Moses received a trophy and will also receive support from board member Carol Dealey, who is a Research Fellow at the University Hospital Birmingham NHS Foundation Trust and University of Birmingham. Originally from Zimbabwe, Moses Murandu studied midwifery in South Africa and also studied in Atlanta, Georgia, before coming to the UK to study a Masters at Birmingham University, supported by Professor Colette Clifford. As well as lecturing at the University of Wolverhampton, he is currently studying for a doctorate at Birmingham. University of Wolverhampton


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):